Viewpoints

In light of the rising rates of sexually transmitted infections (STIs), urgent care clinics have found themselves at a crucial crossroads. PCR (Polymerase Chain Reaction) testing at the point of care emerges as a potential game-changer.

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.

Trichomoniasis, commonly known as “trich,” is one of the most common sexually transmitted infections (STIs). It is caused by a one-celled parasite, Trichomonas vaginalis. Men and women are affected by this infection, but it occurs more often in women.

Watch video highlights from “The Neglected Epidemic: A Panel Discussion about the Value Rapid POC PCR brings to Reproductive Health” panel discussion at the 2022 IDSOG Annual Meeting.

Visby brings point-of-care PCR to the deep south with an appearance at NACCHO360.

Offering a high-quality scientific meeting covering all aspects in the field of chlamydia research, this symposium provides an excellent opportunity for specialists and trainees in sexual health, HIV medicine, public health, microbiology, epidemiology and behavioral science to share their ideas and experiences.

Respiratory diseases are a leading cause of death worldwide. Get an overview of the most common respiratory diseases, their causes, and treatments.

COVID, Influenza A and B, and RSV may be similar in symptoms, but they need to be treated differently. Learn the difference here.

Early treatment prevents spreading the infection to others. If you are sexually active, it is important to get tested regularly at your healthcare provider, an urgent care, or other local clinic that specializes in treating these infections. Testing is the only way to know for sure if you have an STI.

Visby Medical will be exhibiting at the ACOG Annual Clinical and Scientific Meeting (ACSM). ACSM has long been a gathering of the leading women’s health care experts.

We don’t know. The symptoms of the disease are nonspecific, and many people are not even aware they carry the virus. In fact, the CDC estimates that 40% of people with coronavirus symptoms show no symptoms, with other researchers suggesting the rate may be even higher.

The global COVID-19 pandemic touches and disrupts every aspect of life and livelihood across geographies. Despite progress with public health practices and vaccinations, our personal and professional futures face uncertainty. Inconsistent and ambiguous re-opening procedures hinder a robust return to pre-pandemic routines that can restore productivity and economic health.

With the COVID-19 vaccine being distributed and overall infection rates stabilizing, people are beginning to talk about life after the pandemic. Anxious to get back to some kind of normality, even if it means adopting a new normal that includes continued mask wearing and physical distancing, businesses are making plans to open back up.

PCR’s superpower lies in its super sensitivity, which enables it to sniff out even low levels of a pathogen in minutes. Here’s how it works.

Personal PCR could one day become as common as the common cold. In the future, the device will deliver lab accurate results anywhere and to anyone — forever changing our relationship with diagnostics.

Now that Visby has received EUA for our Personal PCR Test to be deployed in moderate-complexity CLIA-certified labs, we’re taking it to the front line of the fight against COVID-19. Each device is personal to individual patients, with results delivered to a lab technician in less than 30 minutes.